Vaidya Sane Ayurved Laboratories Limited

NSEI:MADHAVBAUG Stock Report

Market Cap: ₹1.5b

Vaidya Sane Ayurved Laboratories Balance Sheet Health

Financial Health criteria checks 6/6

Vaidya Sane Ayurved Laboratories has a total shareholder equity of ₹588.7M and total debt of ₹11.3M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are ₹721.4M and ₹132.7M respectively. Vaidya Sane Ayurved Laboratories's EBIT is ₹41.0M making its interest coverage ratio -5.5. It has cash and short-term investments of ₹194.0M.

Key information

1.9%

Debt to equity ratio

₹11.32m

Debt

Interest coverage ratio-5.5x
Cash₹193.97m
Equity₹588.66m
Total liabilities₹132.71m
Total assets₹721.37m

Recent financial health updates

No updates

Recent updates

Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues

Nov 08
Investors Aren't Entirely Convinced By Vaidya Sane Ayurved Laboratories Limited's (NSE:MADHAVBAUG) Revenues

Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?

Aug 25
Should You Be Adding Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) To Your Watchlist Today?

Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Jun 11
Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Financial Position Analysis

Short Term Liabilities: MADHAVBAUG's short term assets (₹324.9M) exceed its short term liabilities (₹113.6M).

Long Term Liabilities: MADHAVBAUG's short term assets (₹324.9M) exceed its long term liabilities (₹19.1M).

Debt to Equity History and Analysis

Debt Level: MADHAVBAUG has more cash than its total debt.

Reducing Debt: MADHAVBAUG's debt to equity ratio has reduced from 86.1% to 1.9% over the past 5 years.

Debt Coverage: MADHAVBAUG's debt is well covered by operating cash flow (621.8%).

Interest Coverage: MADHAVBAUG earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 17:07
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vaidya Sane Ayurved Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution